Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Bio Vitos Pharma AB
AB
Active
Org 5568115272
Nanna Svartz Väg 4, 171 65
Solna
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2010 · 16 years old
0 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Bio Vitos Pharma AB
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (2)
JR
John Robert Nyholm
Chief Auditor
Chief Auditor
2026
SR
Sven Rohmann
Chief Executive Officer
Chief Executive Officer
2025
Former (3)
JJ
Jon Jesper Birgemo
Chief Executive Officer
Chief Executive Officer
2022 – 2025
FP
Filip Patrik Laurin
Chief Auditor
Chief Auditor
2022 – 2025
JA
Joen Anders Emil Averstad
Chief Executive Officer
Chief Executive Officer
2023 – 2023
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
RA
Robert Arinthian Simmons
Board of Directors
Board of Directors
2025
Former (14)
HJ
Hans-Olof Joakim Friis
Board of Directors
Board of Directors
2024 – 2024
JE
John Erik Sebastian Brauns
Board of Directors
Board of Directors
2024 – 2025
PH
Per Hjalmar Olof Didrikson
Board of Directors
Board of Directors
2023 – 2023
VS
Vidar Sung Osen
Board of Directors
Board of Directors
2025 – 2026
JF
Jenni Fredrika Björnulfson
Board of Directors
Board of Directors
2022 – 2022
AM
Anders Mathias Karlsson
Board of Directors
Board of Directors
2022 – 2024
IL
Igor Lokot
Board of Directors
Board of Directors
2022 – 2024
LR
Lars Richard Sperrling Wall
Chairman
Chairman
2022 – 2025
HT
Helge Trettø Olsen
Chairman
Chairman
2025 – 2026
BL
Bo Lars Christer Ziedén
Board of Directors
Board of Directors
2024 – 2025
MA
Måns Anders Alfvén
Deputy Board Member
Deputy Board Member
2022 – 2022
AK
Anna Karin Klevby Dalgaard
Chairman
Chairman
2023 – 2023
TM
Torbjörn Mattias Koivisto
Board of Directors
Board of Directors
2022 – 2022
KC
Karin Cecilia Dahllöf
Board of Directors
Board of Directors
2022 – 2024
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Bio Vitos Pharma AB
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
